Latest News
News Functions
Additional Functions
11 June 2015
Oxford Immunotec
Oxford Immunotec Announces First Patient Enrolled in REACT Trial for T-SPOT.CMV
5 May 2015
Oxford Immunotec
Oxford Immunotec Reports First Quarter 2015 Financial Results
27 April 2015
Oxford Immunotec
Oxford Immunotec Announces CE Mark Approval for T-SPOT.CMV Test
23 April 2015
Oxford Immunotec
Oxford Immunotec Schedules First Quarter 2015 Earnings Release and Conference Call for May 5, 2015
31 March 2015
Oxford Immunotec
Oxford Immunotec Announces Availability of the T-SPOT.CMV Test in the United States
24 March 2015
Oxford Immunotec
Oxford Immunotec Recognizes World TB Day Through Support of the Winner of the Sir John Crofton Award
17 March 2015
Oxford Immunotec
Oxford Immunotec Appoints Stephen M. Gansler as Senior Vice President and Global Head of Human Resources
3 March 2015
Oxford Immunotec
Oxford Immunotec Reports Fourth Quarter and Full Year 2014 Financial Results
20 February 2015
Oxford Immunotec
Oxford Immunotec to Present at the Cowen and Company 35th Annual Health Care Conference
19 February 2015
Oxford Immunotec
Oxford Immunotec Schedules Fourth Quarter and Full Year 2014 Earnings Release and Conference Call for March 3, 2015
5 February 2015
Oxford Immunotec
Oxford Immunotec Announces First Patients Enrolled in PROTECT Trial for T-SPOT.CMV and T-SPOT.PRT
4 February 2015
Oxford Immunotec
Oxford Immunotec Global PLC Announces Closing of Underwritten Offering of Ordinary Shares and Underwriters’ Exercise of Option to Purchase Additional Shares
30 January 2015
Oxford Immunotec
Oxford Immunotec Global PLC Announces Pricing of Underwritten Offering of Ordinary Shares
28 January 2015
Oxford Immunotec
Oxford Immunotec Global PLC Announces Proposed Underwritten Offering of Ordinary Shares
27 January 2015
Oxford Immunotec
Oxford Immunotec to Present at the 2015 Leerink Global Healthcare Conference
6 January 2015
Oxford Immunotec
Oxford Immunotec Announces Completion of Re-Registration in China for T-SPOT.TB Test
22 December 2014
Oxford Immunotec
Oxford Immunotec to Present at the 33rd Annual J.P. Morgan Healthcare Conference
2 December 2014
Oxford Immunotec
James R. Tobin, Former CEO of Boston Scientific, Joins Oxford Immunotec Board of Directors
4 November 2014
Oxford Immunotec
Oxford Immunotec to Host Technology Day
Oxford Immunotec
Oxford Immunotec Reports Third Quarter 2014 Financial Results
24 October 2014
Oxford Immunotec
Oxford Immunotec Schedules Third Quarter 2014 Earnings Release and Conference Call for November 4, 2014
5 August 2014
Oxford Immunotec
Oxford Immunotec Announces Purchase of Assets of Boulder Diagnostics Inc.
Oxford Immunotec
Oxford Immunotec Reports Second Quarter 2014 Financial Results
Oxford Immunotec
Oxford Immunotec Announces Purchase of Assets of Boulder Diagnostics Inc.
Oxford Immunotec
Oxford Immunotec Reports Second Quarter 2014 Financial Results
23 July 2014
Oxford Immunotec
Oxford Immunotec Schedules Second Quarter 2014 Earnings Release and Conference Call for August 5, 2014
Oxford Immunotec
Oxford Immunotec Schedules Second Quarter 2014 Earnings Release and Conference Call for August 5, 2014
7 July 2014
Oxford Immunotec
Oxford Immunotec Appoints Louis O’Dea Chief Medical Officer
Oxford Immunotec
Oxford Immunotec Appoints Louis O’Dea Chief Medical Officer
6 May 2014
Oxford Immunotec
Oxford Immunotec Reports First Quarter 2014 Financial Results